CClinicalTrials.gg
CompletedNCT02339870Updated Feb 15, 2016

Expressive Writing in Improving the Wellbeing or Comforting Capacity of Caregivers of Patients With Cancer

An interventional study of Psychosocial Support for Caregiver and Psychosocial Support for Caregiver in Caregiver, sponsored by University of Washington. Completed at 1 site in United States. Open to participants aged 19 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-02-15.

Sponsored by University of Washington · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Study summary

This randomized clinical trial studies expressive writing in improving the wellbeing or comforting capacity of caregivers of patients with cancer. Expressive writing is a type of intervention that asks people to write about important topics (in this case participants' experience with their spouses'/partners' cancer) and their emotions/feelings surrounding them. Expressive writing, including benefit finding and traumatic disclosure, may be a type of at-home-therapy that caregivers can utilize in an attempt to increase their own wellbeing, offer better comfort to cancer patients, and by association, help cancer patients cope with and manage the cancer experience.

Read the detailed description

PRIMARY OBJECTIVES:

I. To test whether one, or both, types of expressive writing impact spouses of cancer survivors' reported emotional wellbeing and reported ability to provide comfort as compared to a control group.

OUTLINE: Patients are randomized to 1 of 2 arms or assigned to a control arm.

ARM I (EXPRESSIVE DISCLOSURE): Participants complete an anonymous 20 minute writing exercise at home on their computer once per week for 2 weeks (days 2, 9, and 16 for a total of 3 sessions). Participants write about their emotions pertaining to managing and providing care for the cancer patient.

ARM II (BENEFIT FINDING): Participants complete an anonymous 20 minute writing exercise at home on their computer once per week for 2 weeks (days 2, 9, and 16 for a total of 3 sessions). Participants write about any benefits that have arisen because of the cancer diagnosis.

ARM III (CONTROL): Participants complete an anonymous 20 minute writing exercise at home on their computer once per week for 2 weeks (days 2, 9, and 16 for a total of 3 sessions). Participants write about an emotionally neutral topic.

After completion of study, participants are followed up at day 17.

02

Conditions studied

  • Caregiver
03

In context

Lead sponsor

University of Washington is the lead sponsor of 1,397 studies on the registry; 225 are open to participants now.

Of its 154 completed or terminated interventional studies of FDA-regulated products, 132 (86%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Participants must be a spouse or domestic partner of a cancer survivor and will be recruited via the Hematopoietic Stem Cell Transplant Database at Fred Hutchinson Cancer Research Center (FHCRC)
  • Participants must have been in their spousal relationship for at least the past 1 year

Exclusion criteria

Exclusion Criteria:

  • If participants are unable to access a computer they will be excluded
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Arm I (expressive disclosure)

    Participants complete an anonymous 20 minute writing exercise at home on their computer once per week for 2 weeks (days 2, 9, and 16 for a total of 3 sessions). Participants write about their emotions pertaining to managing and providing care for the cancer patient.

    Other: Psychosocial Support for Caregiver · Other: Questionnaire Administration

  • Experimental
    Arm II (benefit finding)

    Participants complete an anonymous 20 minute writing exercise at home on their computer once per week for 2 weeks (days 2, 9, and 16 for a total of 3 sessions). Participants write about any benefits that have arisen because of the cancer diagnosis.

    Other: Psychosocial Support for Caregiver · Other: Questionnaire Administration

  • Sham comparator
    Arm III (control)

    Participants complete an anonymous 20 minute writing exercise at home on their computer once per week for 2 weeks (days 2, 9, and 16 for a total of 3 sessions). Participants write about an emotionally neutral topic.

    Other: Questionnaire Administration · Other: Sham Intervention

Interventions

  • OtherPsychosocial Support for Caregiver

    Complete expressive disclosure writing

  • OtherPsychosocial Support for Caregiver

    Complete benefit finding writing

  • OtherQuestionnaire Administration

    Ancillary studies

  • OtherSham Intervention

    Complete writing on an emotionally neutral topic

06

What researchers measure

Primary outcomes

  1. Change in comforting sensitivity (i.e. quality of social support), measured through writing exercise and anonymous online survey

    Will be reported pre- to post-test for both treatment groups compared to the control group. Repeated measures analysis of variance (ANOVA) within/between interaction will be used.

    Time frame: Baseline to day 17

  2. Change in comforting sensitivity (support quality), measured through writing exercise and anonymous online survey

    Compared between women and men in both treatment groups using paired samples t-test.

    Time frame: Baseline to day 17

  3. Change in degree of stress pre- to post-test in predicting an increase in comforting strategies, measured through writing exercise and anonymous online survey

    Will be analyzed using multiple linear regression.

    Time frame: Up to day 17

  4. Change in emotion regulation over time, measured through writing exercise and anonymous online survey

    Will be compared between traumatic disclosure participants and the control group and between benefit finding participants and the control group using repeated measures ANOVA within/between interaction.

    Time frame: Baseline to day 17

  5. Change in stress, measured through writing exercise and anonymous online survey

    Will be compared between women and men in both treatment groups using paired samples t-test.

    Time frame: Baseline to day 17

  6. Change in stress, perceived burden, and emotion regulation over time, measured through writing exercise and anonymous online survey

    Will be compared between traumatic disclosure participants and the control group and between benefit finding participants and the control group using repeated measures ANOVA within/between group interaction.

    Time frame: Baseline to day 17

  7. Change in use of cognitive mechanism words in expressive writing in predicting significantly higher increases in comforting sensitivity (support quality), measured through writing exercise and anonymous online survey

    Will be analyzed using multiple linear regression.

    Time frame: Baseline to day 17

  8. Changes in emotion regulation in predicting an increase in comforting strategies, measured through writing exercise and anonymous online survey

    Will be analyzed using multiple linear regression.

    Time frame: Up to day 17

  9. Degree of stress, perceived burden, and emotion regulation in predicting comforting sensitivity (i.e. social support quality), measured through writing exercise and anonymous online survey

    Analyzed using linear multiple regression.

    Time frame: Up to day 17

  10. Post-test emotion regulation scores, measured through writing exercise and anonymous online survey

    Compared between traumatic disclosure and benefit finding groups using post-hoc analyses of repeated measures ANOVA.

    Time frame: Up to day 17

  11. Use of emotion-related words in predicting differences in comforting sensitivity (support quality), measured through writing exercise and anonymous online survey

    Will be analyzed using multiple linear regression.

    Time frame: Up to day 17

07

Study locations

1 site
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
    Seattle, Washington 98109, United States
08

References and documents

Publications

  • Harvey J, Berndt M. Cancer caregiver reports of post-traumatic growth following spousal hematopoietic stem cell transplant. Anxiety Stress Coping. 2021 Jul;34(4):397-410. doi: 10.1080/10615806.2020.1845432. Epub 2020 Nov 15. PubMed 33190518 ↗
  • Harvey J, Sanders E, Ko L, Manusov V, Yi J. The Impact of Written Emotional Disclosure on Cancer Caregivers' Perceptions of Burden, Stress, and Depression: A Randomized Controlled Trial. Health Commun. 2018 Jul;33(7):824-832. doi: 10.1080/10410236.2017.1315677. Epub 2017 May 3. PubMed 28467137 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 15, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02339870
Lead sponsor
University of Washington
Collaborators
National Cancer Institute (NCI)
Responsible party
Sponsor
First posted
Jan 16, 2015
Start date
Apr 2015
Primary completion
Jan 2016
Completion
Jan 2016
Last update
Feb 15, 2016

Study contacts

Linda Ko
principal investigator · Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion